Skip to main content
. 2022 Mar 29;145(3):1018–1028. doi: 10.1093/brain/awab378

Figure 1.

Figure 1

Representative Ki map for a healthy subject and a de novo Parkinson’s disease patient. Characteristically predominant reduction in 18F-DOPA uptake rate in the caudal putamen contralateral to the most affected clinical side is highlighted with a black arrow.